Short-term effectiveness of golimumab for ulcerative colitis: Observational multicenter study

To evaluate the real-world effectiveness of golimumab in ulcerative colitis (UC) and to identify predictors of response.We conducted an observational, prospective and multi-center study in UC patients treated with golimumab, from September 2014 to September 2015. Clinical activity was assessed at week 0 and 14 with the physician's global clinical assessment (PGA) and the partial Mayo score. Colonoscopies and blood tests were performed, following...